.
MergerLinks Header Logo

New Deal


Announced

NMS Capital-backed Flourish Research to invest in Excel Medical Clinical Trials.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

clinical trials

United States

Single Bidder

Medical Services

Private

Friendly

Pending

Minority

Acquisition

Domestic

Synopsis

Edit

NMS Capital-backed Flourish Research, a clinical trial site network, agreed to invest in Excel Medical Clinical Trials, a clinical research site. Financial terms are not disclosed. “The Excel partnership expands our geographic footprint and complements our therapeutic areas of focus by bringing many years of Cardiology expertise to the platform. Following the CTT transaction with the Excel Medical partnership validates the consolidation opportunity that exists in the space and represents an important step to solidifying Flourish Research as a leading integrated site network providing its partners the highest level of clinical trial data. We are thrilled to partner with Dr. Baum and welcome him and Excel management to the Flourish Research team,” Luis Gonzalez, NMS Partner.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US